Royalty Pharma Plc (RPRX) Institutional Ownership and Insiders Activity

Royalty Pharma Plc (RPRX) is widely held by institutional investors, with 689 firms reporting positions valued at approximately $20.21B based on SEC Form 13F filings for the quarter ended September 30, 2026.

Morgan Stanley is the largest disclosed holder, reporting approximately $2.40B in RPRX holdings in its latest filing.

Recent insider activity includes 14 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.

Institutional Holders

689

Total Reported Value

$20.21B

Largest Holder

Morgan Stanley

Largest Position

$2.40B

Insider Transactions (90d)

14

Latest Filing Quarter

Q3 2026

New Institutional Positions

103

Funds Exiting Positions

59